A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- 26 November 2015
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 373 (22), 2103-2116
- https://doi.org/10.1056/nejmoa1511939
Abstract
The most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes remain uncertain.Keywords
This publication has 38 references indexed in Scilit:
- Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the ElderlyHypertension, 2010
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- Principal Results of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)Hypertension Research, 2008
- Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood PressureHypertension, 2006
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Predominance of Isolated Systolic Hypertension Among Middle-Aged and Elderly US HypertensivesHypertension, 2001
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990